Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GLPG | Amsterdam | EUR | Real-time | |
GLPGa | BATS Europe | EUR | Delayed | |
GLPG | NASDAQ | USD | Real-time | |
GLPGF | OTC Markets | USD | Delayed | |
GLPG | Vienna | EUR | Real-time |
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It develops transformational medicines in areas of high unmet need by combining internal with external science with the goal to add years of life and improve quality of life of patients across the globe. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. The Company acquired CellPoint and AboundBio in order to develop a cell therapy, which is a potential transformative treatment of different types of cancer.
Name | Age | Since | Title |
---|---|---|---|
Paulus A. Stoffels | 61 | 2022 | CEO, Chairman, Interim Head of R&D |
Jerome Contamine | 66 | 2022 | Lead Independent Non-Executive Director |
Elisabeth Svanberg | 62 | 2020 | Independent Non-Executive Director |
Daniel P. O'Day | 59 | 2019 | Non-Executive Non-Independent Director |
Susanne Schaffert | 56 | 2023 | Non-Executive Independent Director |
Daniel G. Baker | 72 | 2022 | Non-Executive Independent Director |
Peter Guenter | 61 | 2019 | Independent Non-Executive Director |
Linda Slanec Higgins | 61 | 2019 | Non-Executive Non-Independent Director |
Simon J. Sturge | 64 | 2023 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review